icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Cost-effectiveness of Combination Daclatasvir-Sofosbuvirfor
Genotype 3 Chronic Hepatitis C Infection in the United States

 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Catherine Saint-Laurent Thibault,1DivyaMoorjaney,2Michael L. Ganz,2Bruce Sill,3ShaliniHede,3Yong Yuan,3AnupamaKalsekar,3Boris Gorsh3
1Evidera, Montreal, QC, Canada; 2Evidera, Lexington, MA, USA; 3Bristol-Myers Squibb Company, Plainsboro, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif